US5770198A
(en)
*
|
1988-05-18 |
1998-06-23 |
The Research Foundation Of The State Of New York |
Platelet-specific chimeric 7E3 immunoglobulin
|
US5169930A
(en)
*
|
1990-01-05 |
1992-12-08 |
La Jolla Cancer Research Foundation |
Fibronectin receptor
|
US7132260B2
(en)
*
|
1991-04-05 |
2006-11-07 |
The General Hospital Corporation |
DNA encoding parathyroid hormone receptor
|
US7150974B1
(en)
|
1991-04-05 |
2006-12-19 |
The General Hospital Corporation |
Parathyroid hormone receptor binding method
|
WO1992017602A1
(en)
*
|
1991-04-05 |
1992-10-15 |
The General Hospital Corporation Office Of Technology Affairs |
Parathyroid hormone receptor and dna encoding same
|
CA2153228A1
(en)
*
|
1993-01-08 |
1994-07-21 |
Shiu-Lan Ng Chiang |
Peptide inhibitors of cell adhesion
|
AU6235294A
(en)
*
|
1993-02-02 |
1994-08-29 |
Scripps Research Institute, The |
Methods for producing polypeptide binding sites
|
US5753230A
(en)
*
|
1994-03-18 |
1998-05-19 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of angiogenesis
|
US6056958A
(en)
*
|
1994-12-09 |
2000-05-02 |
Dupont Pharmaceuticals |
Method of treatment of arterial and venous thromboembolic disorders
|
PT719859E
(pt)
*
|
1994-12-20 |
2003-11-28 |
Merck Patent Gmbh |
Anticorpo monoclonal anti-alfa v-integrina
|
US5817768A
(en)
*
|
1995-06-07 |
1998-10-06 |
The New York Blood Center, Inc. |
Monospecific antibodies against a subunit of fibrinogen
|
RU2194528C2
(ru)
|
1996-05-31 |
2002-12-20 |
Дзе Скриппс Рисерч Инститьют |
Способы и композиции, используемые для ингибирования ангиогенеза
|
WO1998009651A1
(fr)
*
|
1996-09-03 |
1998-03-12 |
Chugai Seiyaku Kabushiki Kaisha |
COMPLEXES D'ANTICORPS ANTI-INTEGRINE α3
|
DE69739295D1
(de)
*
|
1996-12-09 |
2009-04-23 |
Merck Patent Gmbh |
Löslicher, rekombinanter alphaV beta3 Adhäsionsrezeptor
|
US6596850B1
(en)
|
1998-01-30 |
2003-07-22 |
Ixsys, Incorporated |
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
|
US6590079B2
(en)
*
|
1997-01-30 |
2003-07-08 |
Ixsys, Incorporated |
Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
|
US20010011125A1
(en)
*
|
1997-01-30 |
2001-08-02 |
William D. Huse |
Anti-alpha v beta 3 recombinant human antibodies, nucleic acids encoding same and methods of use
|
DE69828154T2
(de)
*
|
1997-03-12 |
2005-06-23 |
Smithkline Beecham Corp. |
Anti-alphavbeta3 humanizierte monoklonale antikörper
|
PT973550E
(pt)
|
1997-04-11 |
2003-01-31 |
Searle & Co |
Anticorpos antagonistas anti-integrina avb3
|
US6193968B1
(en)
|
1997-04-11 |
2001-02-27 |
The Burnham Institute |
Methods for using anti-αvβ3 integrin antibody
|
US6210904B1
(en)
*
|
1997-10-14 |
2001-04-03 |
Merck & Co., Inc. |
Anticoagulant test
|
DE19828068C2
(de)
*
|
1998-06-24 |
2003-12-18 |
Peter Dietsch |
Mittel zur spezifischen Hemmung osteoklastärer Knochenresorption
|
WO2000009143A1
(en)
*
|
1998-08-13 |
2000-02-24 |
G.D. Searle & Co. |
Multivalent avb3 and metastasis-associated receptor ligands
|
IL143514A0
(en)
*
|
1998-12-04 |
2002-04-21 |
Novartis Ag |
METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ3
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US6159443A
(en)
*
|
1999-04-29 |
2000-12-12 |
Vanderbilt University |
X-ray guided drug delivery
|
US7049140B1
(en)
|
1999-04-29 |
2006-05-23 |
Vanderbilt University |
X-ray guided drug delivery
|
US6531580B1
(en)
*
|
1999-06-24 |
2003-03-11 |
Ixsys, Inc. |
Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
|
US6037176A
(en)
*
|
1999-06-25 |
2000-03-14 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of integrin beta 3 expression
|
MXPA02002488A
(es)
*
|
1999-09-08 |
2002-08-12 |
Bayer Ag |
Direccion de farmacos mediada por integrinas.
|
DK1223980T3
(da)
*
|
1999-10-28 |
2003-09-15 |
Seyedhossein Aharinejad |
Anvendelse af CSF-1-inhibitorer
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
DE60118186T2
(de)
*
|
2000-05-12 |
2006-12-28 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
Verwendung von inhibitoren des plazenta wachstumsfactors für die behandlung einer pathologischen angiogenese, pathologischen arteriogenese, entzündung, tumorbildung und/oder gefässdurchlässigkeit (ödem)
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US7220824B1
(en)
|
2000-08-28 |
2007-05-22 |
Bayer Aktiengesellschaft |
Integrin-mediated drug targeting
|
EP1219305A1
(de)
*
|
2000-12-27 |
2002-07-03 |
Bayer Aktiengesellschaft |
Konjugate von Integrinrezeptorantagonisten und einem zytostatischen Mittel mit spezifisch spaltbaren Linkergruppen
|
CN1507354A
(zh)
*
|
2001-03-02 |
2004-06-23 |
ͨ��ҽ�ƹ�˾ |
通过给予整合蛋白αvβ3拮抗剂并与其它预防或治疗药剂配合来预防或者治疗炎性疾病或自身免疫疾病的方法
|
US7306925B2
(en)
|
2001-11-09 |
2007-12-11 |
Vanderbilt University |
Phage antibodies to radiation-inducible neoantigens
|
US7906102B2
(en)
|
2001-10-03 |
2011-03-15 |
Vanderbilt University |
Ligands to radiation-induced molecules
|
CA2478239A1
(en)
*
|
2002-03-04 |
2003-09-18 |
Medimmune, Inc. |
The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
|
WO2003075741A2
(en)
*
|
2002-03-04 |
2003-09-18 |
Medimmune, Inc. |
METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
|
JP2005535572A
(ja)
*
|
2002-04-12 |
2005-11-24 |
メディミューン,インコーポレーテッド |
組換え抗インターロイキン−9抗体
|
US20050186204A1
(en)
*
|
2002-06-28 |
2005-08-25 |
Peter Carmeliet |
Use of antibodies against FLT-1 for the treatment of osteoporosis
|
WO2004002525A1
(en)
*
|
2002-06-28 |
2004-01-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Use of antibodies against flt-1 for the treatment of osteoporosis
|
CA2514653A1
(en)
*
|
2003-01-30 |
2004-08-12 |
Medimmune, Inc. |
Uses of integrin alphavbeta3 antagonists
|
US7354584B2
(en)
|
2003-04-11 |
2008-04-08 |
Medimmune, Inc. |
Recombinant IL-9 antibodies
|
US20070185077A1
(en)
*
|
2003-07-15 |
2007-08-09 |
Washington University |
Methods of treating, preventing and inhibiting cancer metastasis and tumor formation
|
US7271245B2
(en)
*
|
2004-02-13 |
2007-09-18 |
The Scripps Research Institute |
Methods and compositions for inhibition of metastasis
|
US7351739B2
(en)
*
|
2004-04-30 |
2008-04-01 |
Wellgen, Inc. |
Bioactive compounds and methods of uses thereof
|
US8187595B2
(en)
|
2004-05-07 |
2012-05-29 |
The University Of North Carolina At Chapel Hill |
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I
|
JP4928443B2
(ja)
*
|
2004-05-07 |
2012-05-09 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
インスリン様成長因子iを増強または阻害するための方法
|
BRPI0510915A
(pt)
|
2004-06-04 |
2007-11-13 |
Genentech Inc |
método para o tratamento da esclerose múltipla e artigo manufaturado
|
AU2005299355A1
(en)
|
2004-10-27 |
2006-05-04 |
Medimmune, Llc |
Modulation of antibody specificity by tailoring the affinity to cognate antigens
|
CA2601267C
(en)
|
2005-03-24 |
2014-02-18 |
Thromb-X N.V. |
Novel anti-plgf antibody
|
WO2007003609A1
(en)
*
|
2005-06-30 |
2007-01-11 |
Vib Vzw |
Treatment of liver cirrhosis and its complications
|
MY149159A
(en)
|
2005-11-15 |
2013-07-31 |
Hoffmann La Roche |
Method for treating joint damage
|
WO2008011216A2
(en)
*
|
2006-05-16 |
2008-01-24 |
Pro-Pharmaceuticals, Inc. |
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
|
EP2043603A4
(de)
|
2006-07-11 |
2010-10-27 |
Arubor Corp |
Prävention und therapie von rhinosinusitis mit proinflammatorischen zytokinhemmern
|
EP2079483A4
(de)
*
|
2006-07-29 |
2010-10-20 |
Robert Lamar Bjork Jr |
Bispezifische monoklonale antikörper (spezifisch für cd3 und cd11b)-therapeutische arzneimittelsysteme
|
LT2068889T
(lt)
|
2006-08-10 |
2020-02-10 |
Roy C. Levitt |
Anakinra, naudojama bronchiolito obliteranso sindromo gydymui
|
AR073295A1
(es)
|
2008-09-16 |
2010-10-28 |
Genentech Inc |
Metodos para tratar la esclerosis multiple progresiva. articulo de fabricacion.
|
JP5522717B2
(ja)
*
|
2008-09-19 |
2014-06-18 |
国立大学法人佐賀大学 |
アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法
|
MX2011003428A
(es)
|
2008-10-02 |
2011-07-29 |
Vib Vzw |
Inhibicion del factor de crecimiento placentario (plgf) para tratar la leucemia con cromosoma filadelfia positivo.
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
US20110256055A1
(en)
*
|
2008-12-23 |
2011-10-20 |
Ge Healthcare Limited |
Application of 99mtc peptide-based compound as a bone marrow imaging agent
|
LT3912643T
(lt)
|
2009-02-13 |
2023-02-10 |
Immunomedics Inc. |
Imunokonjugatai su ląstelės viduje skaldoma jungtimi
|
EP3009455A1
(de)
|
2009-09-16 |
2016-04-20 |
Immunomedics Inc. |
Klasse-i-anti-cea-antikörper und verwendungen davon
|
CA2782194C
(en)
|
2009-12-02 |
2018-01-16 |
Immunomedics, Inc. |
Combination of radiolabelled antibodies (rait) and antibody-drug conjugates (adc) for treatment of pancreatic cancer
|
CN103501825B
(zh)
|
2011-05-02 |
2017-03-15 |
免疫医疗公司 |
用于小体积施用的同种异型选择的抗体的超滤浓缩
|
AU2012321082B2
(en)
|
2011-12-01 |
2015-03-12 |
Oxurion NV |
Improving trabeculectomy outcome
|
WO2013101771A2
(en)
|
2011-12-30 |
2013-07-04 |
Genentech, Inc. |
Compositions and method for treating autoimmune diseases
|
TW201334789A
(zh)
|
2012-01-31 |
2013-09-01 |
Genentech Inc |
抗ige抗體及其使用方法
|
WO2014028560A2
(en)
|
2012-08-14 |
2014-02-20 |
Ibc Pharmaceuticals, Inc. |
T-cell redirecting bispecific antibodies for treatment of disease
|
JP2015533117A
(ja)
|
2012-08-31 |
2015-11-19 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
インスリン様成長因子1(igf−1)を増強または阻害するためのモノクローナル抗体
|
CN107753954A
(zh)
|
2012-12-13 |
2018-03-06 |
免疫医疗公司 |
功效改进且毒性降低的抗体与sn‑38的免疫缀合物的剂量
|
WO2014130648A1
(en)
|
2013-02-20 |
2014-08-28 |
Galectin Therapeutics, Inc. |
Method for treatment of pulmonary fibrosis
|
WO2015126548A1
(en)
|
2014-02-21 |
2015-08-27 |
Ibc Pharmaceuticals, Inc. |
Disease therapy by inducing immune response to trop-2 expressing cells
|
CN106029098A
(zh)
|
2014-02-25 |
2016-10-12 |
免疫医疗公司 |
人源化rfb4抗cd22抗体
|
EP3160504B1
(de)
|
2014-06-24 |
2020-09-16 |
Immunomedics, Inc. |
Antihistontherapie für vaskuläre nekrose bei schwerer glomerulonephritis
|
US10449261B2
(en)
|
2014-07-24 |
2019-10-22 |
Washington University |
Compositions targeting radiation-induced molecules and methods of use thereof
|
CN117138060A
(zh)
|
2014-10-07 |
2023-12-01 |
免疫医疗公司 |
抗体-药物缀合物的新辅助剂用途
|
CN107428837A
(zh)
|
2015-04-22 |
2017-12-01 |
免疫医疗公司 |
循环trop‑2阳性癌细胞的分离、检测、诊断和/或鉴定
|
SI3313443T1
(sl)
|
2015-06-25 |
2023-11-30 |
Immunomedics, Inc. |
Kombiniranje protiteles proti HLA-DR ali proti TROP-2 z zaviralci mikrotubulov, zaviralci PARP, zaviralci brutonove kinaze ali zaviralci fosfoinozitid 3-kinaze pomembno izboljša izid zdravljenja pri raku
|
SI3316885T1
(sl)
|
2015-07-01 |
2021-09-30 |
Immunomedics, Inc. |
Imunokonjugati protitelo-SN-38 z linkerjem CL2A
|
JP2018529747A
(ja)
|
2015-10-06 |
2018-10-11 |
ジェネンテック, インコーポレイテッド |
多発性硬化症を治療するための方法
|
EP3207937A1
(de)
|
2016-02-17 |
2017-08-23 |
Royal College of Surgeons in Ireland |
Verfahren zur behandlung oder prävention von sepsis
|
KR102101561B1
(ko)
*
|
2018-07-25 |
2020-04-20 |
가톨릭대학교 산학협력단 |
신생혈관 표적용 조영제 조성물 및 이의 제조방법
|
US20220133913A1
(en)
*
|
2019-07-24 |
2022-05-05 |
Korea Basic Science Institute |
SINGLE DOMAIN ANTIBODY TARGETING aVB3 INTEGRIN
|
US20240082347A1
(en)
|
2021-01-22 |
2024-03-14 |
Royal College Of Surgeons In Ireland |
Treatment of coronavirus
|
EP4342497A1
(de)
|
2021-05-10 |
2024-03-27 |
Kawasaki Institute of Industrial Promotion |
Antikörper mit reduzierter bindungsaffinität für antigen
|